Pituitary

Article	Citations
A Pituitary Society update to acromegaly management guidelines	185
COVID-19 and the pituitary	77
Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review	46
Descriptive epidemiology of craniopharyngiomas in the United States	40
Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 131 patients with acromegaly	32
Skull base repair following endonasal pituitary and skull base tumour resection: a systematic review	32
Managing pasireotide-associated hyperglycemia: a randomized, open-label, Phase IV study	29
Pituitary society expert Delphi consensus: operative workflow in endoscopic transsphenoidal pituitary adenoma resection	29
Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement	28
Mice with gene alterations in the GH and IGF family	26
Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States	25
Consensus on criteria for acromegaly diagnosis and remission	25
Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome	24
Pre-operative serum inflammation-based scores in patients with pituitary adenomas	22
Diabetes insipidus after endoscopic transsphenoidal surgery: multicenter experience and development of the SALT score	21
Selective resection of cushing microadenoma guided by preoperative hybrid 18-fluoroethyl-L-tyrosine and 11-C-methionine PET/MRI	20
Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis	19
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome	19
Cephalocaudal tumor diameter is a predictor of diabetes insipidus after endoscopic transsphenoidal surgery for non-functioning pituitary adenoma	18
Machine learning in predicting early remission in patients after surgical treatment of acromegaly: a multicenter study	18
Diagnostic value of Knosp grade and modified Knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta‐analysis	18
Opioids and pituitary function: expert opinion	17
Virtual magnetic resonance elastography has the feasibility to evaluate preoperative pituitary adenoma consistency	17
Differences between immunotherapy-induced and primary hypophysitis—a multicenter retrospective study	17
Cushing’s disease: adrenal steroidogenesis inhibitors	17

Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice	17
Cardiovascular health and mortality in Cushing’s disease	17
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression	16
Real-world experience with pasireotide-LAR in resistant acromegaly: a single center 1-year observation	16
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	16
The direct and indirect impact of the COVID-19 pandemic on the care of patients with pituitary disease: a cross sectional study	16
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile	16
Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers	16
Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing’s disease	16
Neural network modeling for prediction of recurrence, progression, and hormonal non-remission in patients following resection of functional pituitary adenomas	16
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	15
Complication avoidance protocols in endoscopic pituitary adenoma surgery: a retrospective cohort study in 514 patients	15
Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system	15
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications	15
Epidemiology of common and uncommon adult pituitary tumors in the U.S. according to the 2017 World Health Organization classification	15
The NETting of pituitary adenoma: a gland illusion	15
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	14
Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers	14
Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas	14
Endocrine disorders after primary gamma knife radiosurgery for pituitary adenomas: A systematic review and meta-analysis	14
Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples	14
Normative data for pituitary size and volume in the general population between 50 and 66 years	14
HOMA-IR in acromegaly: a systematic review and meta-analysis	14
Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly	14
Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age	14
Modern imaging in Cushing’s disease	14
Gut microbiota in patients with newly diagnosed acromegaly: a pilot cross-sectional study	13
Glucocorticoid receptor blockers	13
Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results	13
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)	13
Prolactin immunoassay: does the high-dose hook effect still exist?	13
Targeted therapies in the medical management of craniopharyngioma	12
Predictive factors of postoperative diabetes insipidus in 333 patients undergoing transsphenoidal surgery for non-functioning pituitary adenoma	12
Quality of life impairment after a diagnosis of Cushing’s syndrome	12
AIP variant causing familial prolactinoma	12
Novel approaches to bone comorbidity in Cushing’s disease: an update	12
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	12
Genetics of Cushing’s disease: from the lab to clinical practice	11
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	11
Frailty does not preclude surgical success after endoscopic transsphenoidal surgery for pituitary adenomas	11
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity	10
Prevalence of Nelson’s syndrome after bilateral adrenalectomy in patients with cushing’s disease: a systematic review and meta-analysis	10
Pituitary stalk interruption syndrome: phenotype, predictors, and pathophysiology of perinatal events	10
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	10
Surgical outcomes of medically failed prolactinomas: a systematic review and meta-analysis	10
Refractory nonfunctioning pituitary adenomas	9
Professor Rathke’s gift to neurosurgery: the cyst, its diagnosis, surgical management, and outcomes	9
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas	9
Rathke’s cleft cyst infections and pituitary abscesses: case series and review of the literature	9
Typing of inflammatory lesions of the pituitary	9

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients	9
The epidemiology and management patterns of pediatric pituitary tumors in the United States	9
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	9
Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines	9
Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing’s syndrome)	9
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	9
Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case–control study	8
Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review	8
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER	8
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	8
Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas	8
Machine learning as a clinical decision support tool for patients with acromegaly	8
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	8
Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay	8
Management of prolactinomas in children and adolescents; which factors define the response to treatment?	8
Diagnosis and treatment outcomes of Cushing’s disease during pregnancy	8
Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas	8
A study on clinical outcomes of Rathke’s cleft cyst in patients managed conservatively	8
Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers	8
The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus	8
Clinical and radiographic assessment of peripheral joints in controlled acromegaly	8
Long-term hepatic and cardiac health in patients diagnosed with Sheehan’s syndrome	7
Differences in clinical, hormonal, and radiological presentation and in surgical outcomes in patients presenting with and without pituitary apoplexy. A multicenter study of 245 cases	7
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	7
Evaluation of acromegaly treatment direct costs with respect to biochemical control and follow-up length	7
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma	7
Integrated multi-omics profiling of nonfunctioning pituitary adenomas	7
Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation	7
Growth hormone alters gross anatomy and morphology of the small and large intestines in age- and sex-dependent manners	7
Patient-reported outcomes in patients with acromegaly treated with pegvisomant in the ACROSTUDY extension: A real-world experience	7
Chiasmal herniation following treatment of pituitary macroadenoma	7
Prevalence of coronary calcium deposits in Sheehan’s syndrome patients on long term replacement treatment	7
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	7
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment	7
Biochemical testing to differentiate Cushing’s disease from ectopic ACTH syndrome	7
A systematic literature review to evaluate extended dosing intervals in the pharmacological management of acromegaly	7
Pituitary acting drugs: cabergoline and pasireotide	7
How to manage intolerance to dopamine agonist in patients with prolactinoma	7
Refractory lactotroph adenomas	7
Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system	6
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	6
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis	6
Effectiveness of the intraoperative magnetic resonance imaging during endoscopic endonasal approach for acromegaly	6
Identification of mutant K-RAS in pituitary macroadenoma	6
A prospective study on the efficacy of oral estrogen in female patients with acromegaly	6
Characteristics and overall survival in pediatric versus adult pituitary adenoma: a National Cancer Database analysis	6
Hypercoagulability in Cushing’s syndrome: incidence, pathogenesis and need for thromboprophylaxis protocols	6
Hypopituitarism and pregnancy: clinical characteristics, management and pregnancy outcome	6
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	6
Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood	6
Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis	6
Pituitary tumor centers of excellence for Cushing’s disease	6
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review	6
Acromegaly and pregnancy: a systematic review and meta-analysis	6
Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	6
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery	6
Genetics, clinical features and outcomes of non-syndromic pituitary gigantism: experience of a single center from Sao Paulo, Brazil	6
Responsiveness to DDAVP in Cushing’s disease is associated with USP8 mutations through enhancing AVPR1B promoter activity	6
Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing’s disease	6
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	6
Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature	6
Functioning gonadotroph adenomas in premenopausal women: clinical and molecular characterization and review of the literature	6
Pituitary apoplexy and panhypopituitarism following acute leptospirosis	5
Long-term safety of gamma knife radiosurgery (SRS) for acromegaly	5
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	5
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells	5
Healthcare utilization and costs among prolactinoma patients: a cross-sectional study and analysis of determinants	5
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	5
Venous thromboembolism chemical prophylaxis after endoscopic trans-sphenoidal pituitary surgery	5
Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism	5
Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas	5
POU1F1 mutations in combined pituitary hormone deficiency: differing spectrum of mutations in a Western-Indian cohort and systematic analysis of world literature	5
Acromegaly is associated with a distinct oral and gut microbiota	5
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence	5
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	5
Discrimination between non-functioning pituitary adenomas and hypophysitis using machine learning methods based on magnetic resonance imaging‑derived texture features	5
Transcriptome profiling of insulin sensitive tissues from GH deficient mice following GH treatment	5
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	5
Management of sellar and parasellar tumors becoming symptomatic during pregnancy: a practical algorithm based on multi-center experience and systematic literature review	5
Quality of life after long-term biochemical control of acromegaly	5

Giant prolactinoma in children and adolescents: a single-center experience and systematic review	5
Increased oxytocin release precedes hyponatremia after pituitary surgery	5
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	4
Deficiency of WFS1 leads to the impairment of AVP secretion under dehydration in male mice	4
Impact of patient-reported nasal symptoms on quality of life after endoscopic pituitary surgery: a prospective cohort study	4
Surgically treated acromegaly patients have a similar quality of life whether controlled by surgery or requiring additional medical therapy (QuaLAT Study)	4
Changing presentation of acromegaly in half a century: a single-center experience	4
Pituitary metastases: a case series and scoping review	4
Psychological well-being and illness perceptions in patients with hypopituitarism	4
Thyrotropin-secreting pituitary adenomas induce left atrial enlargement with subclinical atrial fibrillation: an echocardiographic study	4
Role of Radiation in the treatment of Cushing Disease	4
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	4
Regional genotypic variations in normosmic congenital hypogonadotropic hypogonadism: our experience and systematic review	4
Refractory somatotroph adenomas	4
The role of the dentist and orthodontist in recognizing oro-facial manifestations of acromegaly: a questionnaire-based study	4
Pituitary and COVID-19 vaccination: a systematic review	4
Double adenomas of the pituitary reveal distinct lineage markers, copy number alterations, and epigenetic profiles	4
Machine learning models predict delayed hyponatremia post-transsphenoidal surgery using clinically available features	4
Surgical outcomes and quality of life in Rathke’s cleft cysts undergoing endoscopic transsphenoidal resection: a multicentre study and systematic review of the literature	4
Familial neurohypophyseal diabetes insipidus: clinical, genetic and functional studies of novel mutations in the arginine vasopressin gene	4
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	4
Predictive value of macular ganglion cell-inner plexiform layer thickness in visual field defect of pituitary adenoma patients: a case-control study	4
Evaluating the burden of endogenous Cushing’s syndrome using a web-based questionnaire and validated patient-reported outcome measures	4
Internal carotid artery stenosis and risk of cerebrovascular ischemia following stereotactic radiosurgery for recurrent or residual pituitary adenomas	4
Safety of endoscopic endonasal biopsy for the pituitary stalk-hypothalamic lesions	4
The treatment of aggressive prolactinomas with everolimus	4
Fully endoscopic endonasal approach for the treatment of intrasellar arachnoid cysts	3
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	3
Endoscopic endonasal marsupialization of rathke cleft cysts: clinical outcomes and risk factors analysis of visual impairment, pituitary dysfunction, and CSF leak	3
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	3
GnRH agonist-associated pituitary apoplexy: a case series and review of the literature	3
Impact of histopathological classification of non-functioning adenomas on long term outcomes: comparison of the 2004 and 2017 WHO classifications	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3
Antiplatelet and anticoagulation therapy and the risk of pituitary apoplexy in pituitary adenoma patients	3
Correction: consensus on criteria for acromegaly diagnosis and remission	3
Historical and future trends in emergency pituitary referrals: a machine learning analysis	3
An Infundibular Unidentified Object (IUO): a new pituitary stalk marker?	3
Cushing’s disease: role of bilateral adrenalectomy	3
Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas	3
Chiasmapexy for secondary empty sella syndrome: diagnostic and therapeutic considerations	3
Co-expression of intermediate filaments glial fibrillary acidic protein and cytokeratin in pituitary adenoma	3
Overnight 1 mg dexamethasone suppression test and 24 h urine free cortisol—accuracy and pitfalls when screening for Cushing’s syndrome	3
Pituitary apoplexy score, toward standardized decision-making: a descriptive study	3
Patient-reported outcomes in refractory hormone-producing pituitary adenomas: an unmet need	3
Mental health disorders in newly diagnosed non-functional pitutary adenoma under initial observation: an observational cohort study using the nationwide MarketScan database	3
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	3